South San Francisco, California
The Discovery Proteomics group is seeking a postdoctoral research fellow within the Rose lab to investigate the mechanisms underlying protein and peptide presentation leading to tumor recognition by the immune system. This project aims to develop new quantitative mass spectrometry (MS) approaches in order to dissect early steps of the antigen-processing pathway and better understand the process in which cancer neoantigen epitopes are presented to the immune system.
The successful candidate should be innovative and capable of working independently to establish methods, carry out experiments, and perform computational data analysis. Additionally, a successful candidate will have experience in biochemical and cellular experimentation (e.g., tissue culture, immunoprecipitation, western blot) using mammalian tumor cells. Previous experience performing mass spectrometry, particularly immunopeptidomics, experiments is desirable - but not required.
A PhD in the area of biochemistry, biology, immunology, cellular/molecular biology, or a closely related field.
Previous experience performing mass spectrometry experiments is desirable, but not required.
A strong work ethic, a steadfast commitment to discovery research and a documented ability to initiate, drive and complete significant research projects, as evidenced by a strong publication record.
Excellent communication and organization skills and the ability to work in a highly interactive and collaborative environment
More information about the Genentech Postdoctoral Program:
Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Diversity and Inclusion (D&I) are critical to the success of our company and our impact on society. We believe that by championing diversity of background, thought and experience, we can foster a sense of belonging and provide an environment where every employee feels valued, included, and able to contribute their best for the patients we serve. We’re focused on attracting, retaining, developing and advancing our people to their full potential by rewarding bold ways of thinking and integrating inclusive behaviors into every aspect of our work.
The next step is yours. To apply today, click on the "Apply for this job" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
These are our stories - stories of the obstacles and opportunities that define and celebrate the unique people at Genentech.